Skip to main content

MassBio Town Hall - What Election Results Mean for the Biopharma Industry

Robert A. Sherman, Senior Counsel in Greenberg Traurig's Boston office, will be a featured speaker at the Massachusetts Biotechnology Council (MassBio) Town Hall webinar "What Election Results Mean for the Biopharma Industry" on Thursday, November 5. Sherman will join Robert K. Coughlin, President & CEO of MassBio, and Tamar Thompson, Vice President of U.S. Government Affairs for Alexion Pharmaceuticals, Inc., to discuss the results of the 2020 Presidential election and what they mean for the future of the biopharma industry.